Preclinical Assessment of the PI3Kα Selective Inhibitor Inavolisib and Prediction of Its Pharmacokinetics and Efficacious Dose in Human.
Salphati L, Pang J, Plise EG, Cheong J, Braun MG, Friedman LS, Hong Thibodeau R, Jaochico A, Johnson R, Liu N, Nannini M, Sampath D, Song K, Hannan EJ, Staben ST.
Salphati L, et al. Among authors: friedman ls.
Xenobiotica. 2024 Oct 10:1-20. doi: 10.1080/00498254.2024.2415103. Online ahead of print.
Xenobiotica. 2024.
PMID: 39387185